Newsletter

More on MFTH


MFTH is trading near a 52wk low and significantly lower from where it was just a few months ago.

View Chart: http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=mfth&insttype=&freq=1&show=&time=7 

Could recent developments send it back to test previous highs?

The medical industry has many problems that need correcting and one of them is the amount of preventable errors that occur each year. MFTH could be a big help in solving this problem!

According to MFTH's website:

- There is at least one medication error per hospital patient per day (Institute of Medicine).
- 400,000 preventable drug related injuries per year.
- Up to 98,000 Americans die each year due to medical errors by healthcare professionals.

MFTH's solution is a protector incorporating locking mechanism which ensures that medicinal substance cannot be released from the needle without positive pre-matching substance / specific patient.

* Protector fits over proportion of medicine assembly.
* Protector includes bar code & locking element.
* Locking element released electronically on positive match

Imagine if one day MFTH's solution is found in every hospital!

Last month MFTH announced that they have closed an agreement to receive a $5 million equity investment. What makes this especially significant is who is behind the investment!

The $5 million Equity Funding Facility was signed with Centurion Private Equity, LLC ("Centurion"), an institutional investor managed by Roswell Capital Partners, LLC.
Roswell Capital Partners, LLC is a fund management company focused on private equity investments in small-cap publicly traded securities.

Since 1994, its members have served in the Private Equity Markets as the Principal or Investment Banker for over 125 public companies including several biotechnology companies such as Celgene, and Peregrine Pharmaceuticals!

Celgene is trading over $60 a share right now!

They must believe in MFTH to invest this much money.

MFTH intends to use the funding facility to fund ongoing research and development, and to support general corporate purposes.

MFTH CEO Jacob Elhadad stated, "Through this infusion of funding, Medisafe 1 Technologies will be able to advance rapid efforts to commercialize our life saving devices that prevent the incorrect administration of medicines and transfusions."

"Additional capital will enable the ongoing development of worldwide business activities, and the initiation of pilot programs in hospitals and medical clinics across the world."

MFTH has already garnered interest from multinational medical supplier, Becton, Dickenson!

BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

Just last month BD announced revenues of $961 million for the second quarter ended March 31, 2001. This is the largest quarterly revenues reported in the history of the Company!!

BD has expressed interest in learning more about MFTH's patented products and solutions for possible business collaboration. This could be something colossal!

"Medisafe 1 continues to garner interest from leading firms in the healthcare industry," said Jacob Elhadad, CEO of MFTH. "We are pleased by the inquiries we have received, particularly from multinational corporations that are interested in potentially marketing and distributing our preventative solutions."




For more information on MFTH, visit their website at: http://www.medisafe1.com

Please do your due diligence and consult with a financial professional.

*********************************************************

This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockEgg.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. StockEgg.com does not provide trading, investment or tax advice, and readers shall not rely on statements by StockEgg.com employees which purport to provide such advice. Full disclaimer can be read at http://www.StockEgg.com/disclaimer.htm

Release of Liability: Through use of this website viewing or using you agree to hold StockEgg.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. StockEgg.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockEgg.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead StockEgg.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. StockEgg.com is compliant with the Can Spam Act of 2003. StockEgg.com does not offer such advice or analysis, and StockEgg.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.

StockEgg.com has been compensated by a third party Royal Import Inc. fifty thousand dollars for a one week MFTH advertising services contract. StockEgg.com does not own any shares of MFTH. The third party may have shares and may liquidate it which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1 9 3 3 Securities Act. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. StockEgg.com has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisement should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact the share price of the profiled company negatively. StockEgg.com affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the share price of the security.

The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, StockEgg.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, StockEgg.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. StockEgg.com is not responsible for any claims made by the companies advertised herein, nor is StockEgg.com responsible for any other promotional firm, its program or its structure.